Disclosures - Y. Choi: None. H. Hampson: None. J.D. Weissenkampen: None. J. Kanter: None. T. Vaisar: None. K. Sulek: Employee; Current; Novo Nordisk A/S. K. Bornfeldt: Advisory Panel; Current; ESPERION Therapeutics, Inc. J.A. Schaub: Consultant; Ended; Klick. D. van Raalte: Consultant; Current; AstraZeneca. Research Support; Current; AstraZeneca. Consultant; Current; Boehringer Ingelheim International GmbH. Research Support; Current; Boehringer Ingelheim International GmbH. Consultant; Current; Eli Lilly and Company. Research Support; Current; Eli Lilly and Company. Consultant; Current; Merck & Co., Inc.. Research Support; Current; Merck & Co., Inc.. Consultant; Current; Novo Nordisk. Research Support; Current; Novo Nordisk. K.J. Nadeau: None. S. Eddy: Research Support; Current; AstraZeneca, Eli Lilly and Company, Genentech, Inc., Sanofi, Novo Nordisk A/S, Travere Therapeutics. Other - Royalties administered through University of Michigan; Current; AstraZeneca. Research Support; Current; Certa Therapeutics, Vera Therapeutics, Dimerix. V. Nair: None. P. McCown: None. A.S. Naik: None. M.O. Alaba: None. F. Alakwaa: None. N. Nguyen: None. C. Smith: None. J.B. Hodgin: None. R. Nelson: None. K. Tuttle: Consultant; Ended; Alnylam Pharmaceuticals, Inc.. Consultant; Current; AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc., Novo Nordisk, Lilly, ProKidney. Consultant; Ended; Roche Diabetes Care. Research Support; Ended; Travere. P.E. Ladd: None. E. Zeitler: Consultant; Current; Novo Nordisk. A. Karihaloo: None. M. Kretzler: Research Support; Current; AstraZeneca, Boehringer Ingelheim International GmbH, Bayer AG, Dimerix, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., European Union, JDRF, National Institutes of Health, Novo Nordisk, Sanofi, vera therapeutics, Regeneron Pharmaceuticals Inc., Travere. P. Bjornstad: Consultant; Current; Bayer AG, Boehringer Ingelheim International GmbH, Lilly, Novo Nordisk.

Petter Bjornstad

University of Washington

Appearances